Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30002547
Basic Information
VIS ID
TVIS30002547
Fusion event
HIV-TERF2 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr16
Cytoband
q22.1
Reference genome
GRCh37/hg19
Start
69413681/69379778 (Hg38)
End
69413681/69379778 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA16B
Target gene
TERF2
miRNAs that regulate target gene
hsa-mir-124-3p
;
hsa-mir-26b-5p
;
hsa-mir-766-3p
;
hsa-mir-15b-5p
;
hsa-mir-96-5p
;
hsa-mir-92a-3p
;
hsa-mir-218-5p
;
hsa-mir-5692a
;
hsa-mir-106a-3p
;
hsa-mir-572
;
hsa-mir-4430
;
hsa-mir-3652
;
hsa-mir-593-5p
;
hsa-mir-122-5p
;
hsa-mir-504-3p
;
hsa-mir-3135b
;
hsa-mir-767-5p
;
hsa-mir-183-5p
;
hsa-mir-454-3p
;
hsa-mir-4295
;
hsa-mir-3666
;
hsa-mir-301b-3p
;
hsa-mir-301a-3p
;
hsa-mir-130b-3p
;
hsa-mir-130a-3p
;
hsa-mir-5197-5p
;
hsa-mir-203b-3p
;
hsa-mir-7158-3p
;
hsa-mir-378a-5p
;
hsa-mir-6821-3p
;
hsa-mir-6790-3p
;
hsa-mir-4680-5p
;
hsa-mir-4635
;
hsa-mir-3653-5p
;
hsa-mir-1248
;
hsa-mir-5088-3p
;
hsa-mir-3934-5p
;
hsa-mir-764
;
hsa-mir-125a-3p
;
hsa-mir-129-5p
;
hsa-mir-665
;
hsa-mir-1228-5p
;
hsa-mir-654-5p
;
hsa-mir-541-3p
;
hsa-mir-4683
;
hsa-mir-7160-5p
;
hsa-mir-6134
;
hsa-mir-7854-3p
;
hsa-mir-6884-5p
;
hsa-mir-485-5p
;
hsa-mir-7162-3p
;
hsa-mir-4433a-3p
;
hsa-mir-4459
;
hsa-mir-4768-3p
;
hsa-mir-4478
;
hsa-mir-4419b
;
hsa-mir-3929
;
hsa-mir-6888-5p
;
hsa-mir-23a-3p
;
hsa-mir-1225-3p
;
hsa-mir-1233-3p
;
hsa-mir-1247-3p
;
hsa-mir-139-3p
;
hsa-mir-1827
;
hsa-mir-3940-3p
;
hsa-mir-4649-3p
;
hsa-mir-4722-5p
;
hsa-mir-6746-5p
;
hsa-mir-6808-5p
;
hsa-mir-6893-5p
;
hsa-mir-940
;
hsa-mir-1273g-3p
;
hsa-mir-3120-5p
;
hsa-mir-3664-5p
;
hsa-mir-4252
;
hsa-mir-4522
;
hsa-mir-4793-3p
;
hsa-mir-508-5p
;
hsa-mir-542-3p
;
hsa-mir-6510-3p
;
hsa-mir-6512-3p
;
hsa-mir-661
;
hsa-mir-6720-5p
;
hsa-mir-6742-3p
;
hsa-mir-6776-5p
;
hsa-mir-6849-3p
;
hsa-mir-6888-3p
;
hsa-mir-7703
Nearest miRNA
hsa-mir-1225/Upstream/1146279; hsa-mir-11401/Downstream/186030;
Nearest TSS
ENST00000527434/Upstream/7423;
ENST00000514123/Downstream/4872;
Nearest CpG islands
None/Target,
chr16-CpG: 29/Upstream/39799
,
chr16-CpG: 74/Downstream/5847
Upstream sequence
gaaaattttaaatatttattaattcattagaaaataacaataaactaattacaaggtaacataaataacatccttatgaaaaattacggcatttactaag
Downstream sequence
ataaaagtttaatgagaagggtgacatttgtttttcattttgaaaatctctttaatatctggtttaatatagacgatagctggatgctcataactgcttc
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate